Evidence map›Paper›PMID 39349234›Full record

ReviewActa tropica2024

Wolbachia-based emerging strategies for control of vector-transmitted disease.

Diego Montenegro, Gerardo Cortés-Cortés, María Guadalupe Balbuena-Alonso, Caison Warner, Manel Camps

Abstract readReview
In one paragraph

Review in Acta tropica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Detection of novelFrontiers in microbiology · 2026
    Article
  7. Frontiers in microbiology · 2026
    Article
  8. ModellingJournal of pest science · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. bioRxiv : the preprint server for biology · 2025
    Article
  15. Review
  16. Article
  17. New microbes and new infections · 2025
    Review
  18. Review
  19. Article
  20. Life table variations inFrontiers in insect science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diego MontenegroCorporación Innovation Hub, Monteria 230001, Colombia; Department of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA 95064, USA; Grupo de Investigación: Salud y Tecnología 4.0. Fundación Chilloa, Santa Marta 470001, Colombia.
Gerardo Cortés-CortésDepartment of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA 95064, USA; Posgrado en Microbiología, Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias de la Benemérita Universidad Autónoma de Puebla, Ciudad Universitaria, San Manuel, Puebla 72570, Mexico.
María Guadalupe Balbuena-AlonsoDepartment of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA 95064, USA; Posgrado en Microbiología, Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias de la Benemérita Universidad Autónoma de Puebla, Ciudad Universitaria, San Manuel, Puebla 72570, Mexico.
Caison WarnerDepartment of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA 95064, USA.
Manel CampsDepartment of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA 95064, USA. Electronic address: mcamps@ucsc.edu.

Funding

Development of a Genotype-linked Antibiotic Resistance Platform for Real Time Pathogen Risk Classification and EpidemiologyR41AI122740 · NIAID · MAVERIX BIOMICS, INC. · PI CHAN, PATRICIA · 2016 to 2016
$220k
NIAID NIH HHS R41 AI122740
6 · The paper itself

Abstract

Dengue fever is a mosquito-transmitted disease of great public health importance. Dengue lacks adequate vaccine protection and insecticide-based methods of mosquito control are proving increasingly ineffective. Here we review the emerging use of mosquitoes transinfected with the obligate intracellular bacterium Wolbachia pipientis for vector control. Wolbachia often induces cytoplasmic incompatibility in its mosquito hosts, resulting in infertile progeny between an infected male and an uninfected female. Wolbachia infection also suppresses the replication of pathogens in the mosquito, a process known as "pathogen blocking". Two strategies have emerged. The first one releases Wolbachia carriers (both male and female) to replace the wild mosquito population, a process driven by cytoplasmic incompatibility and that becomes irreversible once a threshold is reached. This suppresses disease transmission mainly by pathogen blocking and frequently requires a single intervention. The second strategy floods the field population with an exclusively male population of Wolbachia-carrying mosquitoes to generate infertile hybrid progeny. In this case, transmission suppression depends largely on decreasing the population density of mosquitoes driven by infertility and requires continued mosquito release. The efficacy of both Wolbachia-based approaches has been conclusively demonstrated by randomized and non-randomized studies of deployments across the world. However, results conducted in one setting cannot be directly or easily extrapolated to other settings because dengue incidence is highly affected by the conditions into which the mosquitoes are released. Compared to traditional vector control methods, Wolbachia-based approaches are much more environmentally friendly and can be effective in the medium/long term. On the flip side, they are much more complex and cost-intensive operations, requiring a substantial investment, infrastructure, trained personnel, coordination between agencies, and community engagement. Finally, we discuss recent evidence suggesting that the release of Wolbachia-transinfected mosquitoes has a moderate potential risk of spreading potentially dangerous genes in the environment.

Indexed as

AedesDengueMosquito VectorsPest Control, BiologicalWolbachiaAnimalsFemaleHumansMaleVector Borne DiseasesArbovirusesBiocontrolEnvironmental riskGenetically modified organismGenomicsSymbiosisWolbachia pipientis

Identifiers

PMID39349234
PMCPMC11637914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.